Cityland Development (PHS:CDC) 1-Year Sharpe Ratio: -0.51 (As of Jul. 05, 2026)


PHS:CDC Cityland Development Corp PHS:CDC
44 GF Score
Price ₱0.61
GF Value ₱0.75
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Cityland Development 1-Year Sharpe Ratio?

Cityland Development PHS:CDC +3.39% 44 1-Year Sharpe Ratio is -0.51 as of Jul. 05, 2026. GuruFocus rates PHS:CDC with a GF Score™ of 44/100 and a GF Value™ of ₱0.75 (Modestly Undervalued). The stock has 4 warning signs investors should review.

The 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk over the past year. As of today (2026-07-05), Cityland Development's 1-Year Sharpe Ratio is -0.51.

Cityland Development  (PHS:CDC) 1-Year Sharpe Ratio Explanation

The 1-Year Sharpe Ratio inidicates the risk-adjusted return of an investment over the past year. It is calculated as the annualized result of the average monthly excess return divided by its standard deviation over the past year. The monthly excess return is the monthly investment return minus the monthly risk-free rate (typically the 10-year Treasury Constant Maturity Rate). If the risk-free rate for a specific region is not available, U.S. data is used by default.

The greater a portfolio's Sharpe Ratio, the better its risk-adjusted performance. A negative Sharpe Ratio means the risk-free rate is greater than the portfolio’s historical or projected return, or else the portfolio's return is expected to be negative.

Cityland Development 1-Year Sharpe Ratio Related Terms

PHS:CDC vs CBRE, BEKE, JLL: 1-Year Sharpe Ratio Comparison

For the Real Estate Services subindustry, Cityland Development's 1-Year Sharpe Ratio, along with its competitors' market caps and 1-Year Sharpe Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cityland Development 1-Year Sharpe Ratio vs Real Estate Industry

For the Real Estate industry and Real Estate sector, Cityland Development's 1-Year Sharpe Ratio distribution charts can be found below:

* The bar in red indicates where Cityland Development's 1-Year Sharpe Ratio falls into.


PHS:CDC
44GF Score
Cityland Development Corp PHS:CDC
1-Year Sharpe Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cityland Development 1-Year Sharpe Ratio Calculation

The 1-Year Sharpe Ratio measures the performance of an investment such as a stock or portfolio compared to a risk-free asset. A stock / portfolio's 1-Year Sharpe Ratio can be calculated by dividing the difference between the one-year returns of the investment and the risk-free rate, by the standard deviation of the investment returns over one year.

Frequently Asked Questions Learn more about 1-Year Sharpe Ratio →
What does a 1-Year Sharpe Ratio of -0.51 mean?
Cityland Development (PHS:CDC) has a 1-Year Sharpe Ratio of -0.51 as of Jul. 05, 2026. 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk. View historical data for Cityland Development and its competitors.
Is Cityland Development's 1-Year Sharpe Ratio too high?
Cityland Development's current 1-Year Sharpe Ratio is -0.51. Overall, Cityland Development has a GF Score™ of 44/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Cityland Development's 1-Year Sharpe Ratio compare to CBRE and BEKE?
Cityland Development's 1-Year Sharpe Ratio of -0.51 can be compared against companies in the Real Estate industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 1-Year Sharpe Ratio for a Real Estate company?
A good 1-Year Sharpe Ratio depends on the Real Estate industry context. However, 1-Year Sharpe Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 1-Year Sharpe Ratio mean?
A high 1-Year Sharpe Ratio can signal that a stock is expensive relative to its fundamentals. 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk. View historical data for Cityland Development and its competitors. Cityland Development's current 1-Year Sharpe Ratio is -0.51. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cityland Development stock overvalued right now?
Based on GuruFocus' analysis, Cityland Development (PHS:CDC) is currently considered Modestly Undervalued. The stock's GF Value™ is ₱0.75, compared to a current price of ₱0.61 — trading 18.7% below its estimated fair value. The current 1-Year Sharpe Ratio is -0.51. Cityland Development's overall GF Score™ is 44/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 1-Year Sharpe Ratio calculated?
1-Year Sharpe Ratio is calculated from a company's financial statements. For Cityland Development (PHS:CDC), the current 1-Year Sharpe Ratio is -0.51 as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cityland Development (PHS:CDC) Overvalued in 2026?

Based on GuruFocus' analysis, Cityland Development stock appears to be undervalued. The current stock price of ₱0.61 is trading 18.7% below its estimated GF Value™ of ₱0.75. GuruFocus considers Cityland Development to be Modestly Undervalued.

Key valuation signals for PHS:CDC:

  • 1-Year Sharpe Ratio: -0.51
  • GF Value™: ₱0.75 vs. price of ₱0.61 (18.7% below fair value)
  • GF Score™: 44/100 with 4 warning signs

No single metric tells the full story. See the PHS:CDC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cityland Development Business Description

Address 156 H.V. Dela Costa Street, 3rd Floor, Cityland Condominium 10, Tower II, Makati, PHL, 1226
Cityland Development Corp operates as a real estate company that acquire, develop, improve, subdivide, cultivate, lease, sublease, sell, exchange, barter and/or dispose of agricultural, industrial, commercial, residential and other real properties, as well as to construct, improve, lease, sublease, sell and/or dispose of houses, buildings and other improvements thereon, and to manage and operate subdivisions and housing projects or otherwise engage in the financing and trading of real estate. Its operations are carried through the following segments: Sale of Real Estate Properties, Lease of Real Estate Properties, and Pension Plan Operations. The Company derives its revenues from the sale and lease of real estate properties and its investments in trust funds.
44GF Score

Get the complete analysis for PHS:CDC

1-Year Sharpe Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₱0.61
Price
₱0.75
GF Value